Renub Research
www.renub.com
USA Cardiovascular Devices Market Trends
and Forecast (2010 – 2015)
Publisher: Renub Research
Published: October, 2011
USA Cardiovascular Device - Market Overview
One in three American adults has some form of Cardiovascular Disease (CVD). Heart disease
and stroke are the most common cardiovascular diseases. These are the first and third leading
causes of death for both men and women in the United States. Cardiovascular Disease
includes high blood pressure, coronary heart disease, heart failure and stroke. It is the
leading cause of death in America and the World.
United States cardiovascular devices market is expected to be over US$ 35 Billion by 2015,
with a compound annual growth rate of approximately 7% from the period of 2011 to 2015.
The cardiovascular device market is expected to be driven by increase in the incidence of
cardiovascular diseases, an ageing population and greater adoption of technological
advancements.
The most rapidly growing segments in the cardiovascular device market are interventional
cardiology, cardiac rhythm management, and cardiovascular prosthetic device market.
Cardiac Rhythm Management devices market is one of the major contributing segments
expected to generate more than US$ 16 Billion by 2015. Interventional cardiology devices
represent one of the fastest developing areas in the overall cardiovascular device market
which is expected to touch US$ 12 Billion by 2015.
An increasing demand for minimally invasive surgeries amongst the rapidly aging population is
expected to spark further growth in the cardiovascular devices market. Moreover, the cost
efficiencies offered by lesser invasive methods expect to garner much favor amongst the
healthcare payers in the coming years.
Report Details
“USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)” report published
by Renub Research provides an in-depth analysis of the past, present and future prospects.
The report has been researched at source globally and features latest available data covering:
© Renub Research Page 2 of 17
United States Cardiovascular Device Market (2006 - 2015)
Top 6 cardiovascular device segment (Cardiac Rhythm Management, Interventional
Cardiology , Cardiovascular Surgery, Cardiovascular Prosthetic, Peripheral Vascular &
Cardiovascular Monitoring & Diagnostic Device) market data from 2006 to 2015
Top 12 cardiovascular devices (Implantable Cardioverter Defibrillator, Pacemaker,
Cardiac Resynchronization Therapy-Pacemaker, Angioplasty, Angiography, PTCA
Baloon, Coronary Stent, Anastomosis, Endoscopic Vessel Harvesting, Ventricular Assist
Device, Heart Valve, Prothetic Heart Valve) market data from 2006 to 2015
Mergers and Acquisitions in the Cardiovascular Device market
Key drivers of growth in the Cardiovascular Device market
Key Companies analysis in the Cardiovascular Device market
Research Highlights
More than 81 Million people are estimated to be suffering from CVD in the US
United States cardiovascular device market is expected to over US$ 35 Billion by 2015
Cardiac Rhythm Management devices market is one of the major contributing
segments which is expected to generate more than US$ 16 Billion by 2015
Interventional cardiology devices represent one of the fastest growing segment in the
overall cardiovascular device market
Coronary stent is the fastest growing categories in the interventional cardiology
market it registered a rapid growth due to rapid advancements in the area of drug-
eluting Coronary Stent
M&A activity of cardiovascular device companies is a significant of US$ 31 Billion deals
in 2006
Key Companies Analyzed
This section covers the key facts about the major companies that play an important role in
United States Cardiovascular Market. The key companies analyzed in this section are Sorin
Group, Medtronic, St. Edwards Life Science and St. Jude Medical. All the companies have
© Renub Research Page 3 of 17
been analyzed from three points 1) Revenue of the company from cardiovascular device
segment globally 2) Strength of the company in cardiovascular device segment 3)
Weakness of the company in cardiovascular device segment.
Data Sources
This report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 100 paid databases.
© Renub Research Page 4 of 17
About Us
Renub Research is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have more than 7 years of experience especially
in international Business-to-Business Researches, Surveys, Business and Consulting.
Throughout the years we have acquired expertise in most market sectors, including
Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial
Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive,
Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.
For more information on us or to view any of our sample work you can
mail us at info@renub.com
© Renub Research Page 5 of 17
Published
By
Renub Research
A–116B, Sector–27
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com
© USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)
Renub Research, 2011
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publisher
© Renub Research Page 6 of 17
Table of Contents
1. Executive Summary
2. United States Cardiovascular Device Market & Forecast (2006 – 2015)
3. United States Cardiovascular Device Market & Forecast (2006 – 2015)
3.1 Cardiac Rhythm Management
3.1.1 Implantable Cardioverter Defibrillator
3.1.2 Pacemaker
3.1.3 Cardiac Resynchronization Therapy-Pacemaker (CRT-P)
3.2 Interventional Cardiology
3.2.1 Angioplasty
3.2.2 Angiography
3.2.3 PTCA Balloon
3.2.4 Coronary Stent
3.3 Cardiovascular Surgery
3.3.1 Anastomosis Device
3.3.2 Endoscopic Vessel Harvesting Device
3.3.3 Ventricular Assist Device (VAD)
3.3.4 Heart Valve
3.4 Cardiovascular Prosthetic Device
3.4.1 Prosthetic Heart Valve
3.5 Peripheral Vascular Device
3.6 Cardiovascular Monitoring & Diagnostic Device
4. Growth Drivers in Cardiovascular Device Market
4.1 Aging of the Population
4.2 Obesity
4.3 Smoking
4.4 High Incidence of Cardiovascular Death
5. Challenges
5.1 Significance of Cardiovascular Device Innovation
5.2 Regulation
© Renub Research Page 7 of 17
6. Merger & Acquisition in Cardiovascular Device Market
7. Key Companies
7.1 Sorin
7.1.1 Globally - Sorin Revenue from Cardiovascular Devices
7.1.2 Strength
7.1.3 Weaknesses
7.2 Edwards Lifesciences
7.2.1 Global - St. Edwards Revenue from Cardiovascular Devices
7.2.2 United States - St. Edwards Revenue from Cardiovascular Devices
7.2.3 Strength
7.2.4 Weaknesses
7.3 St. Jude Medical
7.3.1 Globally - St. Jude Revenue from Medical Cardiovascular Devices
7.3.2 Strength
7.3.3 Weaknesses
7.4 Medtronic
7.4.1 Globally – Medtronic Revenue from Cardiovascular Devices
7.4.2 Strength
7.4.3 Weaknesses
© Renub Research Page 8 of 17
List of Figures:
Figure 2-1: United States – Cardiovascular Device Market (Million US$), 2006 – 2010
Figure 2-2: United States – Forecast for Cardiovascular Device Market (Million US$), 2011 – 2015
Figure 3-1: United States – Cardiac Rhythm Management Market (Million US$), 2006 – 2010
Figure 3-2: United States – Forecast for Cardiac Rhythm Management Market (Million US$), 2011 – 2015
Figure 3-3: United States – Implantable Cardioverter Defibrillator Market (Million US$), 2003 – 2010
Figure 3-4: United States – Forecast for Implantable Cardioverter Defibrillator Market (Million US$), 2011
– 2015
Figure 3-5: United States – Pacemaker Market (Million US$), 2003 – 2010
Figure 3-6: United States – Forecast for Pacemaker Market (Million US$), 2011 – 2015
Figure 3-7: United States – CRT-P Market (Million US$), 2005 – 2010
Figure 3-8: United States – Forecast for CRT-P Market (Million US$), 2011 – 2015
Figure 3-9: United States – Interventional Cardiology Market (Million US$), 2006 – 2010
Figure 3-10: United States – Forecast for Interventional Cardiology Market (Million US$), 2011 – 2015
Figure 3-11: United States – Angioplasty Market (Million US$), 2003 – 2010
Figure 3-12: United States – Forecast for Angioplasty Market (Million US$), 2011 – 2015
Figure 3-13: United States – Angiography Market (Million US$), 2003 – 2010
Figure 3-14: United States – Forecast for Angiography Market (Million US$), 2011 – 2015
Figure 3-15: United States – PTCA Balloon Market (Million US$), 2003 – 2010
Figure 3-16: United States – Forecast for PTCA Balloon Market (Million US$), 2011 – 2015
Figure 3-17: United States – Coronary Stent Market (Million US$), 2003 – 2010
Figure 3-18: United States – Forecast for Coronary Stent Market (Million US$), 2011 – 2015
Figure 3-19: United States – Cardiovascular Surgery Market (Million US$), 2006 – 2010
Figure 3-20: United States – Forecast for Cardiovascular Surgery Market (Million US$), 2011 – 2015
Figure 3-21: United States – Forecast for Anastomosis Device Market (Million US$), 2011 – 2015
Figure 3-22: United States – Endoscopic Vessel Harvesting Market (Million US$), 2003 – 2010
Figure 3-23: United States – Forecast for Endoscopic Vessel Harvesting Market (Million US$), 2011 –
2015
Figure 3-24: United States – Ventricular Assist Device Market (Million US$), 2004 – 2010
Figure 3-25: United States – Forecast for Ventricular Assist Device Market (Million US$), 2011 – 2015
Figure 3-26: United States – Heart Valve Market (Million US$), 2004 – 2010
Figure 3-27: United States – Forecast for Heart Valve Market (Million US$), 2011 – 2015
Figure 3-28: United States – Cardiovascular Prosthetic Market (Million US$), 2006 – 2010
Figure 3-29: United States – Forecast for Cardiovascular Prosthetic Market (Million US$), 2011 – 2015
Figure 3-30: United States – Prosthetic Heart Valve Market (Million US$), 2008 – 2010
Figure 3-31: United States – Forecast for Prosthetic Heart Valve Market (Million US$), 2011 – 2015
© Renub Research Page 9 of 17
Figure 3-32: United States – Peripheral Vascular Market (Million US$), 2006 – 2010
Figure 3-33: United States – Forecast for Peripheral Vascular Market (Million US$), 2011 – 2015
Figure 3-34: United States – Cardiovascular Monitoring & Diagnostic Market (Million US$), 2006 – 2010
Figure 3-35: United States – Forecast for Cardiovascular Monitoring & Diagnostic Market (Million US$),
2011 – 2015
Figure 4-1: Population Aged 60 or over: World & Development Regions, 1950 – 2050
Figure 4-2: Old-age Dependency Ratio: Major Areas, 2009 & 2050
Figure 7-1: Global – Sorin Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7-2: Global – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7-3: United States – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7-4: Global – St Jude Medical Cardiovascular Devices Revenue (Million US$), 2007 – 2010
Figure 7-5: Global – Medtronic Cardiovascular Devices Revenue (Million US$), 2007 – 2010
© Renub Research Page 10 of 17
List of Tables:
Table 4-1: Global – Population aged 60 or over, 65 or over and 80 or over by Sex (Thousands)
Table 4-2: Worldwide – Prevalence of Adult Obesity for Developed Countries (Percent %), 2002 – 2005
Table 4-3: Worldwide – Prevalence of Adult Obesity for Developing Countries (Percent %), 1998 – 2005
Table 4-4: United States – Deaths from Cardiovascular Diseases (Thousand), 1900 – 2007
Table 4-5: United States – Forecast for Crude Prevalence (Percent), 2010, 2015, 2020, 2025, 2030
Table 4-6: United States – Forecast for Direct (Medical) costs (Billion US$), 2010, 2015, 2020, 2025,
2030
Table 4-7: United States – Forecast for Indirect (lost productivity) costs (Billion US$), 2010, 2015 2020,
2025, 2030
Table 6-1: Worldwide – Merger & Acquisition (Million US$), 1998 – 2010
© Renub Research Page 11 of 17
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)
Single User Hard Copy CD – Rom Global Site License
(Email from Publisher) (Mail Delivery) (Mail Delivery) (Multiple User License)
US$ 975 US$ 1,075 US$ 1,075 US$ 1,500
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://renub.com/reports/showdetails.aspx?id=50
2) Order by Wire Transfer:
http://renub.com/reports/wiretransfer.aspx?id=50&pid=1178
To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 12 of 17
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 13 of 17
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
A -116B
Sector -27
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch
© Renub Research Page 14 of 17
Related Reports
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)
Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs
Analysis
Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,
Challenges & Future Forecast
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)
Glucose Monitoring Devices Market Worldwide (2010 – 2014)
Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin,
DPP-IV, GLP-1
Asia Medical Tourism Analysis (2008 – 2013)
Global Molecular Diagnostics Market: Opportunities & Future Forecast
Insulin Delivery Devices Market Analysis and Future Forecast
World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments
© Renub Research Page 15 of 17
Our Partial List of Clients
Redbus Bain
Becton Dickinson WAKE Technology Services, Inc.
Pfizer PSS World Medical
Intercell Relypsa
Sanofi Pasteur C&K components
Stanford Burgess Konkuk University
Pequot Capital Resonetics
DMI Samsung
Transgene S.A. SEKISUI MEDICAL CO. LTD.
Ixia communications Plentyoffish Media INC
Toyota Tsusho Amercia Inc. Arthur D Little Gmbh
National Health Research Institutes Morgan Stanley
Abbott Diabetes Care Takeda Pharmaceutical Corporation
Corning Incorporated - Life Sciences Hokkai School of Commerce
L.E.K. Consulting GmbH Ministry of Manpower Singapore
Syntiron GenOmind, LLC.
MediVas LLC Goldman Sachs & Co
Credit Suisse NTT Advanced Technology
Dune Medical Tokyo Womens Medical University
QIAGEN The Chemo-Sero-Therapeutic Research
Inje University Trade Council of Iceland
Mapp Biopharmaceutical Jpmorgan, Ets Trading
Institute for Information Industry GE Healthcare IT
NorDiag ASA ixia communications
© Renub Research Page 16 of 17
Rep e Inv Medicas SA de
Innogenetics
Disclaimer
This research report is published by Renub Research. All rights reserved. Reproduction or
redistribution of this research report in any form for any business purpose is expressly
prohibited without written permission of www.renub.com and any payments of a specified
fee. Requests to republish any material may be sent to us at info@renub.com.
Most of the information available in this report is within the public domain. The submitting
authors or other copyright holders retain rights for reproduction or redistribution. All persons
reproducing or redistributing this information are expected to adhere to the terms and
constraints invoked by the copyright holder. Such protected material, however, may be used
under the terms of "fair use” as defined in the copyright laws, which generally permit use for
non-commercial educational purposes such as teaching, research, criticism, and news
reporting.
With respect to documents available, neither the company nor any of its employees makes
any warranty, express or implied, including the warranties of merchantability and fitness for
a particular purpose, or assumes any legal liability or responsibility for the accuracy,
completeness, or usefulness of any information, apparatus, product, or process disclosed, or
represents that its use would not infringe privately owned rights.
© Renub Research Page 17 of 17